bromopyruvate has been researched along with Local Neoplasm Recurrence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baltazar, F; Bonatelli, M; de Salis, LVV; Dias, MP; Maria-Engler, SS; Pinheiro, C; Pinto, MT; Vital, PDS | 1 |
| Al Marzabani, MM; Attia, YM; El-Abhar, HS; Shouman, SA | 1 |
2 other study(ies) available for bromopyruvate and Local Neoplasm Recurrence
| Article | Year |
|---|---|
3-Bromopyruvate Suppresses the Malignant Phenotype of Vemurafenib-Resistant Melanoma Cells.
Topics: Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Melanoma; Mutation; Neoplasm Recurrence, Local; Phenotype; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Vemurafenib | 2022 |
Targeting glycolysis by 3-bromopyruvate improves tamoxifen cytotoxicity of breast cancer cell lines.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Glycolysis; Humans; Mice; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Pyruvates; Tamoxifen; Xenograft Model Antitumor Assays | 2015 |